| |
| |
|
| Insider
Information: |
Eshelman Fredric N |
| Relationship: |
10% Owner |
| City: |
Wilmington |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
8,151,654 |
|
|
Indirect Shares
|
3,933,809 |
|
|
| Direct
Value |
$95,684,563 |
|
|
|
Indirect Value
|
$13,709,856 |
|
|
| Total
Shares |
12,085,463 |
|
|
| Total
Value |
$109,394,419 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
7
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
-7.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -45.7%
|
-43.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmaceutical Product Developme... |
PPDI |
Executive Chairman, Di... |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director, 10% Owner |
2014-07-02 |
0 |
2014-07-02 |
0 |
Premium* |
|
|
Bausch Health Companies Inc |
BHC |
Director |
2017-05-05 |
38,298 |
2016-03-11 |
0 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
Director, 10% Owner |
2017-11-13 |
250,000 |
2017-11-13 |
3,439,151 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2020-09-11 |
1,292,787 |
2020-09-11 |
319,085 |
Premium* |
|
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2020-11-25 |
6,570,569 |
2020-11-25 |
175,573 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2012-06-01 |
4 |
B |
$19.72 |
$992,291 |
D/D |
50,319 |
2,588,035 |
3.92 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2012-06-13 |
4 |
B |
$18.33 |
$810,058 |
D/D |
44,193 |
2,632,228 |
3.92 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2012-06-14 |
4 |
B |
$19.04 |
$649,892 |
D/D |
34,133 |
2,666,361 |
3.92 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Director |
– • • |
2017-05-22 |
4 |
B |
$15.00 |
$4,500,000 |
I/I |
300,000 |
3,439,151 |
2.25 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Director |
– • • |
2017-11-13 |
4 |
B |
$19.73 |
$4,932,500 |
D/D |
250,000 |
250,000 |
3.92 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • • |
2018-01-29 |
4 |
B |
$10.00 |
$3,350,000 |
D/D |
335,000 |
1,273,428 |
3.92 |
- |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-03-30 |
4 |
B |
$4.76 |
$67,106 |
I/I |
14,100 |
14,100 |
1.5 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-03-31 |
4 |
B |
$4.87 |
$146,112 |
I/I |
30,000 |
44,100 |
1.5 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-04-01 |
4 |
B |
$4.89 |
$220,122 |
I/I |
45,000 |
89,100 |
1.5 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-04-02 |
4 |
B |
$4.96 |
$35,792 |
I/I |
7,223 |
96,323 |
1.5 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-04-03 |
4 |
B |
$4.85 |
$169,740 |
I/I |
35,000 |
131,323 |
1.5 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-04-06 |
4 |
B |
$5.28 |
$233,715 |
I/I |
44,250 |
175,573 |
1.5 |
% |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-07-02 |
4 |
B |
$8.00 |
$15,000,000 |
D/D |
1,875,000 |
7,034,744 |
2.45 |
% |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2006-05-18 |
4 |
D |
$35.96 |
$194,472 |
D/D |
(5,408) |
9,425,118 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-12-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(100,000) |
8,154,626 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2009-06-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,258) |
7,744,368 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2009-08-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(500,000) |
7,244,368 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2010-09-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(37,500) |
462,500 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2010-10-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(38,000) |
424,500 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2011-01-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(15,000) |
409,500 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2011-04-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(15,000) |
394,500 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2011-12-05 |
4 |
D |
$33.25 |
$13,547,480 |
I/I |
(407,443) |
0 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2011-12-05 |
4 |
D |
$33.25 |
$232,242,638 |
D/D |
(6,984,741) |
0 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • • |
2014-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,673,522) |
0 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • • |
2014-07-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(174,495) |
0 |
0 |
- |
|
148 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
